|
Eine Ebene nach oben |
Gruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 2
2019
Bracarda, Sergio; Bamias, Aristotelis; Casper, Jochen; Negrier, Sylvie; Sella, Avishay; Staehler, Michael; Tarazi, Jamal; Felici, Alessandra; Rosbrook, Brad; Jardinaud-Lopez, Monica und Escudier, Bernard
(2019):
Is Axitinib Still a Valid Option for mRCC in the Second-Line Setting? Prognostic Factor Analyses From the AXIS Trial.
In: Clinical Genitourinary Cancer, Bd. 17, Nr. 3, E689-E703
2014
Larkin, James; Fishman, Mayer; Wood, Laura; Negrier, Sylvie; Olivier, Kara; Pyle, Linda; Gorbunova, Vera; Jonasch, Eric; Andrews, Lori und Staehler, Michael
(2014):
Axitinib for the Treatment of Metastatic Renal
Cell Carcinoma. Recommendations for Therapy Management
to Optimize Outcomes.
In: American Journal of Clinical Oncology, Bd. 47, Nr. 4: S. 397-403
[PDF, 153kB]